A detailed history of Telemus Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Telemus Capital, LLC holds 42,299 shares of PFE stock, worth $1.13 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
42,299
Previous 45,184 6.39%
Holding current value
$1.13 Million
Previous $1.5 Million 18.76%
% of portfolio
0.1%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $75,385 - $97,916
-2,885 Reduced 6.39%
42,299 $1.22 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $114,625 - $133,985
-3,572 Reduced 7.33%
45,184 $1.5 Million
Q2 2023

Jul 10, 2023

SELL
$36.12 - $41.79 $66,280 - $76,684
-1,835 Reduced 3.63%
48,756 $1.79 Million
Q1 2023

Apr 11, 2023

BUY
$39.39 - $51.28 $34,505 - $44,921
876 Added 1.76%
50,591 $2.06 Million
Q4 2022

Jan 11, 2023

SELL
$41.75 - $54.5 $114,353 - $149,275
-2,739 Reduced 5.22%
49,715 $0
Q3 2022

Oct 11, 2022

SELL
$43.76 - $53.42 $1,094 - $1,335
-25 Reduced 0.05%
52,454 $2.3 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $60,628 - $71,886
-1,303 Reduced 2.42%
52,479 $2.75 Million
Q1 2022

Apr 06, 2022

SELL
$45.75 - $56.69 $436,180 - $540,482
-9,534 Reduced 15.06%
53,782 $2.78 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $35,245 - $52,246
-853 Reduced 1.33%
63,316 $3.74 Million
Q3 2021

Oct 27, 2021

BUY
$39.25 - $50.42 $213,951 - $274,839
5,451 Added 9.28%
64,169 $2.76 Million
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $55,445 - $62,809
-1,544 Reduced 2.56%
58,718 $2.3 Million
Q1 2021

Apr 20, 2021

SELL
$33.49 - $37.77 $7,200 - $8,120
-215 Reduced 0.36%
60,262 $2.19 Million
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $4,083 - $5,192
122 Added 0.2%
60,477 $2.23 Million
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $33,591 - $39,410
1,058 Added 1.78%
60,355 $2.29 Million
Q2 2020

Jul 17, 2020

BUY
$30.12 - $36.54 $44,547 - $54,042
1,479 Added 2.56%
59,297 $2.01 Million
Q1 2020

Jun 05, 2020

SELL
$27.03 - $38.62 $70,088 - $100,141
-2,593 Reduced 4.29%
57,818 $2.21 Million
Q4 2019

Jan 24, 2020

BUY
$32.92 - $37.36 $29,200 - $33,138
887 Added 1.49%
60,411 $2.37 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $42,172 - $54,684
-1,298 Reduced 2.13%
59,524 $2.14 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $257,713 - $289,352
-6,969 Reduced 10.28%
60,822 $2.25 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $869,025 - $954,768
-23,174 Reduced 25.48%
67,791 $2.88 Million
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $724,620 - $826,146
18,836 Added 26.11%
90,965 $3.97 Million
Q3 2018

Oct 23, 2018

BUY
$34.47 - $41.81 $282,826 - $343,051
8,205 Added 12.84%
72,129 $3.18 Million
Q2 2018

Jul 31, 2018

SELL
$32.98 - $35.16 $31,067 - $33,120
-942 Reduced 1.45%
63,924 $2.32 Million
Q1 2018

Apr 27, 2018

SELL
$31.91 - $37.02 $39,887 - $46,275
-1,250 Reduced 1.89%
64,866 $2.3 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $1.57 Million - $1.67 Million
47,228 Added 250.04%
66,116 $2.39 Million
Q3 2017

Nov 03, 2017

SELL
$31.0 - $34.15 $210,893 - $232,322
-6,803 Reduced 26.48%
18,888 $674,000
Q2 2017

Apr 03, 2018

BUY
N/A
7 Added 0.03%
25,691 $863,000
Q1 2017

Apr 03, 2018

BUY
N/A
25,684
25,684 $879,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.